Verrica Pharmaceuticals Inc. (NasdaqCM: VRCA)
Health Care · Pharmaceuticals · US
$4.08
-0.73% today · +0.2% 1Y
Verrica Pharmaceuticals Inc. (NasdaqCM: VRCA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $70.60M and employs 76 people.
Over the last twelve months the share price has gained 0.2%, trading between 3.28 and 9.82.
Tweenvest scores Verrica Pharmaceuticals Inc. across four factors: quality 34/100, value 62/100. Its strongest factor is value.
VRCA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $70.60M
- Revenue (TTM)
- $30.32M
- P/E
- —
- EPS
- -1.88
- Dividend yield
- —
- Beta (5Y)
- 1.61
- 52-week high
- $9.82
- 52-week low
- $3.28
- Avg volume (3M)
- —
- Shares outstanding
- 17.18M
- Employees
- 76
- Next earnings
- —
About Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
- ISIN
- US92511W2070
- Founded
- 2013
- Listed since
- Jun 15, 2018
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cantourage Group SEXTRA: HIGH | $70.93M | €4.98 | -1.97% |
| Bangkok Lab And Cosmetic Public Company LimitedSET: BLC | $70.81M | ฿3.96 | +0.51% |
| Wanbury LimitedBSE: 524212 | $70.71M | Rs195.85 | -1.58% |
| DongKoo Bio & Pharma Co., Ltd.KOSDAQ: A006620 | $70.70M | ₩3,515.00 | -0.14% |
| Poolbeg Pharma PLCAIM: POLB | $69.71M | £0.07 | -3.90% |
| KOREA PHARMA Co., Ltd.KOSDAQ: A032300 | $69.53M | ₩8,570.00 | -1.72% |
| WITHUS PHARMACEUTICAL Co.,LTD.KOSDAQ: A330350 | $69.12M | ₩7,040.00 | -2.90% |
| NeOnc Technologies Holdings, Inc.NasdaqGM: NTHI | $69.10M | $2.90 | +4.32% |
Figures last refreshed Oct 11, 2026.